On ECHEMI
Home > Drugs > Primary tracheobronchial tumors
Primary tracheobronchial tumors
Primary tracheal and bronchial tumors originating from the mucosal epithelium include squamous cell carcinoma, adenocarcinoma, and papilloma; those originating from the mucosal glands or submucosal glands include adenoid cystic carcinoma and mucoepidermoid carcinoma; those originating from the silver-loving Kulchitsky cells of the mucosal epithelium include poorly differentiated carcinoma and carcinoid; those originating from the interstitial tissue include leiomyoma, hemangioma, chondroma, neurofibroma, hamartoma, carcinosarcoma, etc.
  • Site of disease:

    Tracheothoracic
  • Infectious :

    Not contagious
  • Frequent population:

    It is more common among men over 40 years old who smoke
  • Related symptoms:

    Squamous cell metaplasia Recurrent infection Compression of bronchial tree Cyanosis Tracheal obstruction
  • Concurrent disease:

Related Drugs
Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions
Manufacturer:

Jinhua Enterprise (Group) Co., Ltd. Xi'an Jinhua Pharmaceutical Factory

Bronchitis tablets
Manufacturer:

Jiuzhitang Co., Ltd.

Bronchitis tablets
Manufacturer:

Shaanxi Hualong Pharmaceutical Co., Ltd.

Mannan peptide oral solution
Indication: Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the adverse reactions of radiotherapy and chemotherapy to the hematopoietic system and gastrointestinal reactions.
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.